Atlas Trials

SVR12 in Genotype 3 HCV (F0-F2) Treated With RDV + SOF

Clinical trial NCT07316842 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07316842
Sponsor
Center of target therapy
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Viral Hepatitis C
Start date
2025-09-17
Primary completion
2026-02-02
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.